Rosaceiform dermatitis as a complication of treatment of facial seborrheic dermatitis with 1% pimecrolimus cream.
Gorman
Christopher R
CR
White
Stephen W
SW
D000287:Administration, Topical; D000328:Adult; D012628:Dermatitis, Seborrheic / Q000188:drug therapy*; D003879:Dermatologic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D003875:Drug Eruptions / Q000175:diagnosis / Q000209:etiology*; D005148:Facial Dermatoses / Q000139:chemically induced / Q000188:drug therapy*; D006801:Humans; D008297:Male; D009824:Ointments; D012393:Rosacea / Q000139:chemically induced*; D016559:Tacrolimus / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives*
D003879:Dermatologic Agents; D009824:Ointments; C117268:pimecrolimus; D016559:Tacrolimus